(Total Views: 113)
Posted On: 02/20/2022 9:03:50 AM
Post# of 25099
$STAB News February 15, 2022
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
https://finance.yahoo.com/news/statera-biopha...00996.html
Statera Biopharma, Inc., Announces Central Institutional Review Board Approval of Phase 3 Clinical Trial for Pediatric Crohn’s Disease
https://finance.yahoo.com/news/statera-biopha...00996.html
(0)
(0)Scroll down for more posts ▼
